NRx Pharmaceuticals (Nasdaq: NRXP) Reports Third Quarter 2026 Financial Results and Provides Corporate Update
FDA approved the Company’s first drug, preservative-free ketamine, ahead of its GDUFA goal date; com
FDA approved the Company’s first drug, preservative-free ketamine, ahead of its GDUFA goal date; com